Evidence map›Paper›PMID 25855606›Full record

ReviewNature reviews. Cardiology2015

Long noncoding RNAs in cardiac development and ageing.

Yvan Devaux, Jennifer Zangrando, Blanche Schroen, Esther E Creemers, Thierry Pedrazzini, Ching-Pin Chang, Gerald W Dorn, Thomas Thum, Stephane Heymans, Cardiolinc network

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Cardiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 204 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
204citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

204 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Unifying and unique roles of non-coding RNA biomarkers in liver and heart fibrosis.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2026
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. The molecular mechanisms of cardiac development and related diseases.Signal transduction and targeted therapy · 2024
    Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

144 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yvan DevauxLuxembourg Institute of Health, L-1526 Luxembourg, Luxembourg.
Jennifer ZangrandoLuxembourg Institute of Health, L-1526 Luxembourg, Luxembourg.
Blanche SchroenMaastricht University Medical Centre, 6211 LK Maastricht, Netherlands.
Esther E CreemersAcademic Medical Center, 1105AZ Amsterdam, Netherlands.
Thierry PedrazziniUniversity of Lausanne Medical School, CH-1011 Lausanne, Switzerland.
Ching-Pin ChangIndiana University School of Medicine, Indianapolis, IN 46202, USA.
Gerald W DornWashington University School of Medicine, St. Louis, MO 63110, USA.
Thomas ThumInstitute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, OE 8886, Carl-Neuberg-Strasse 1, D-30625 Hannover, Germany.
Stephane HeymansMaastricht University Medical Centre, 6211 LK Maastricht, Netherlands.
Cardiolinc network

Funding

LncRNA mechanism of heart failureR01HL121197 · NHLBI · INDIANA UNIVERSITY INDIANAPOLIS · PI CHANG, CHING-PIN · 2014 to 2022
$3.8M
Chromatin mechanism of molecular motor gene regulationR01HL118087 · NHLBI · INDIANA UNIVERSITY INDIANAPOLIS · PI CHANG, CHING-PIN · 2013 to 2016
$1.5M
MICRORNA TARGETING IN HEART FAILURER01HL108943 · NHLBI · WASHINGTON UNIVERSITY · PI DORN, GERALD W. · 2012 to 2015
$1.5M
NHLBI NIH HHS HL118087NHLBI NIH HHS HL121197NHLBI NIH HHS R01 HL108943NHLBI NIH HHS R01 HL121197
6 · The paper itself

Abstract

A large part of the mammalian genome is transcribed into noncoding RNAs. Long noncoding RNAs (lncRNAs) have emerged as critical epigenetic regulators of gene expression. Distinct molecular mechanisms allow lncRNAs either to activate or to repress gene expression, thereby participating in the regulation of cellular and tissue function. LncRNAs, therefore, have important roles in healthy and diseased hearts, and might be targets for therapeutic intervention. In this Review, we summarize the current knowledge of the roles of lncRNAs in cardiac development and ageing. After describing the definition and classification of lncRNAs, we present an overview of the mechanisms by which lncRNAs regulate gene expression. We discuss the multiple roles of lncRNAs in the heart, and focus on the regulation of embryonic stem cell differentiation, cardiac cell fate and development, and cardiac ageing. We emphasize the importance of chromatin remodelling in this regulation. Finally, we discuss the therapeutic and biomarker potential of lncRNAs.

Indexed as

AgingAnimalsEpigenesis, GeneticHeartHumansRNA, Long NoncodingRNA, Long Noncoding

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.